Clinical Trial Update: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of oral Ifetroban for diffuse cutaneous systemic sclerosis and SSc-associated pulmonary arterial hypertension, with the study curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis
• Systemic Sclerosis-associated Pulmonary Arterial Hypertension

Drugs mentioned

• Ifetroban (Ifetroban)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Scleroderma, Diffuse, Scleroderma, Systemic | Phase 2 | Status: ACTIVE_NOT_RECRUITING